{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:17:39Z","timestamp":1792171059178,"version":"4.4.0"},"reference-count":265,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12264-025-01519-9","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:45:47Z","timestamp":1760427947000},"page":"2296-2321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Chemokine CCL2 Mediates Neuroglial Crosstalk and Drives Chronic Pain Pathogenesis"],"prefix":"10.1007","volume":"41","author":[{"given":"Junyu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3742-7713","authenticated-orcid":false,"given":"Ceng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7644-1492","authenticated-orcid":false,"given":"Rou-Gang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"1519_CR1","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","volume":"161","author":"SN Raja","year":"2020","unstructured":"Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S. The revised International Association for the Study of Pain definition of pain: Concepts, challenges, and compromises. Pain 2020, 161: 1976\u20131982.","journal-title":"Pain"},{"key":"1519_CR2","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","volume":"397","author":"SP Cohen","year":"2021","unstructured":"Cohen SP, Vase L, Hooten WM. Chronic pain: An update on burden, best practices, and new advances. Lancet 2021, 397: 2082\u20132097.","journal-title":"Lancet"},{"key":"1519_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41577-019-0147-2","volume":"19","author":"P Baral","year":"2019","unstructured":"Baral P, Udit S, Chiu IM. Pain and immunity: Implications for host defence. Nat Rev Immunol 2019, 19: 433\u2013447.","journal-title":"Nat Rev Immunol"},{"key":"1519_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016303","volume":"7","author":"CL Sokol","year":"2015","unstructured":"Sokol CL, Luster AD. The chemokine system in innate immunity. Cold Spring Harb Perspect Biol 2015, 7: a016303.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1519_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107581","volume":"212","author":"BC Jiang","year":"2020","unstructured":"Jiang BC, Liu T, Gao YJ. Chemokines in chronic pain: Cellular and molecular mechanisms and therapeutic potential. Pharmacol Ther 2020, 212: 107581.","journal-title":"Pharmacol Ther"},{"key":"1519_CR6","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/febs.14466","volume":"285","author":"CE Hughes","year":"2018","unstructured":"Hughes CE, Nibbs RJB. A guide to chemokines and their receptors. FEBS J 2018, 285: 2944\u20132971.","journal-title":"FEBS J"},{"key":"1519_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1590\/S1679-45082015RB3438","volume":"13","author":"DC Palomino","year":"2015","unstructured":"Palomino DC, Marti LC. Chemokines and immunity. Einstein (Sao Paulo) 2015, 13: 469\u2013473.","journal-title":"Einstein (Sao Paulo)"},{"key":"1519_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","volume":"32","author":"JW Griffith","year":"2014","unstructured":"Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: Positioning cells for host defense and immunity. Annu Rev Immunol 2014, 32: 659\u2013702.","journal-title":"Annu Rev Immunol"},{"key":"1519_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0074-7742(07)82010-1","volume":"82","author":"RM Ransohoff","year":"2007","unstructured":"Ransohoff RM, Liu L, Cardona AE. Chemokines and chemokine receptors: Multipurpose players in neuroinflammation. Int Rev Neurobiol 2007, 82: 187\u2013204.","journal-title":"Int Rev Neurobiol"},{"key":"1519_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMra052723","volume":"354","author":"IF Charo","year":"2006","unstructured":"Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354: 610\u2013621.","journal-title":"N Engl J Med"},{"key":"1519_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1744-8069-3-33","volume":"3","author":"RR Ji","year":"2007","unstructured":"Ji RR, Suter MR. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007, 3: 33.","journal-title":"Mol Pain"},{"key":"1519_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fimmu.2019.00333","volume":"10","author":"AE Vilgelm","year":"2019","unstructured":"Vilgelm AE, Richmond A. Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy. Front Immunol 2019, 10: 333.","journal-title":"Front Immunol"},{"key":"1519_CR13","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.3390\/ijms19103217","volume":"19","author":"A Ridiandries","year":"2018","unstructured":"Ridiandries A, Tan JTM, Bursill CA. The role of chemokines in wound healing. Int J Mol Sci 2018, 19: 3217.","journal-title":"Int J Mol Sci"},{"key":"1519_CR14","first-page":"17","volume":"2016","author":"A Ridiandries","year":"1856","unstructured":"Ridiandries A, Tan JTM, Bursill CA. The role of CC-chemokines in the regulation of angiogenesis. Int J Mol Sci 1856, 2016: 17.","journal-title":"Int J Mol Sci"},{"key":"1519_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/emmm.201100183","volume":"3","author":"RR Koenen","year":"2011","unstructured":"Koenen RR, Weber C. Chemokines: Established and novel targets in atherosclerosis. EMBO Mol Med 2011, 3: 713\u2013725.","journal-title":"EMBO Mol Med"},{"key":"1519_CR16","first-page":"8342","volume":"7","author":"C Liu","year":"2014","unstructured":"Liu C, Cui G, Zhu M, Kang X, Guo H. Neuroinflammation in Alzheimer\u2019s disease: Chemokines produced by astrocytes and chemokine receptors. Int J Clin Exp Pathol 2014, 7: 8342\u20138355.","journal-title":"Int J Clin Exp Pathol"},{"key":"1519_CR17","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.18632\/oncotarget.1426","volume":"4","author":"PJ Sarvaiya","year":"2013","unstructured":"Sarvaiya PJ, Guo D, Ulasov I, Gabikian P, Lesniak MS. Chemokines in tumor progression and metastasis. Oncotarget 2013, 4: 2171\u20132185.","journal-title":"Oncotarget"},{"key":"1519_CR18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1042\/BJ20071493","volume":"409","author":"M O\u2019Hayre","year":"2008","unstructured":"O\u2019Hayre M, Salanga CL, Handel TM, Allen SJ. Chemokines and cancer: Migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 2008, 409: 635\u2013649.","journal-title":"Biochem J"},{"key":"1519_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1210\/er.2006-0044","volume":"28","author":"M Rotondi","year":"2007","unstructured":"Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P. Role of chemokines in endocrine autoimmune diseases. Endocr Rev 2007, 28: 492\u2013520.","journal-title":"Endocr Rev"},{"key":"1519_CR20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/all.13089","volume":"72","author":"L Castan","year":"2017","unstructured":"Castan L, Magnan A, Bouchaud G. Chemokine receptors in allergic diseases. Allergy 2017, 72: 682\u2013690.","journal-title":"Allergy"},{"key":"1519_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrd4334","volume":"13","author":"RR Ji","year":"2014","unstructured":"Ji RR, Xu ZZ, Gao YJ. Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov 2014, 13: 533\u2013548.","journal-title":"Nat Rev Drug Discov"},{"key":"1519_CR22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev.immunol.26.021607.090326","volume":"26","author":"NV Serbina","year":"2008","unstructured":"Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008, 26: 421\u2013452.","journal-title":"Annu Rev Immunol"},{"key":"1519_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pneurobio.2018.12.001","volume":"173","author":"RE Zigmond","year":"2019","unstructured":"Zigmond RE, Echevarria FD. Macrophage biology in the peripheral nervous system after injury. Prog Neurobiol 2019, 173: 102\u2013121.","journal-title":"Prog Neurobiol"},{"key":"1519_CR24","doi-asserted-by":"publisher","first-page":"F103","DOI":"10.1152\/ajprenal.00202.2014","volume":"308","author":"F Bicer","year":"2015","unstructured":"Bicer F, Altuntas CZ, Izgi K, Ozer A, Kavran M, Tuohy VK, et al. Chronic pelvic allodynia is mediated by CCL2 through mast cells in an experimental autoimmune cystitis model. Am J Physiol Renal Physiol 2015, 308: F103\u2013F113.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1519_CR25","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1073\/pnas.91.9.3652","volume":"91","author":"MW Carr","year":"1994","unstructured":"Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994, 91: 3652\u20133656.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1519_CR26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.neuron.2022.12.009","volume":"111","author":"Z Shi","year":"2023","unstructured":"Shi Z, Yu P, Lin WJ, Chen S, Hu X, Chen S, et al. Microglia drive transient insult-induced brain injury by chemotactic recruitment of CD8+ T lymphocytes. Neuron 2023, 111: 696-710.e9.","journal-title":"Neuron"},{"key":"1519_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cell.2022.12.030","volume":"186","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Yan P, Wang R, Lai J, Tang H, Xiao X, et al. Opioid-induced fragile-like regulatory T cells contribute to withdrawal. Cell 2023, 186: 591-606.e23.","journal-title":"Cell"},{"key":"1519_CR28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1471-4159.2008.05429.x","volume":"106","author":"MA Dansereau","year":"2008","unstructured":"Dansereau MA, Gosselin RD, Pohl M, Pommier B, Mechighel P, Mauborgne A, et al. Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem 2008, 106: 757\u2013769.","journal-title":"J Neurochem"},{"key":"1519_CR29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1471-4159.2007.04969.x","volume":"104","author":"H Jung","year":"2008","unstructured":"Jung H, Toth PT, White FA, Miller RJ. Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root Ganglia neurons. J Neurochem 2008, 104: 254\u2013263.","journal-title":"J Neurochem"},{"key":"1519_CR30","doi-asserted-by":"publisher","first-page":"11603","DOI":"10.1074\/jbc.271.20.11603","volume":"271","author":"T Kurihara","year":"1996","unstructured":"Kurihara T, Bravo R. Cloning and functional expression of mCCR2, a murine receptor for the C-C chemokines JE and FIC. J Biol Chem 1996, 271: 11603\u201311607.","journal-title":"J Biol Chem"},{"key":"1519_CR31","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.4049\/jimmunol.159.4.1993","volume":"159","author":"S Sozzani","year":"1997","unstructured":"Sozzani S, Luini W, Borsatti A, Polentarutti N, Zhou D, Piemonti L, et al. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 1997, 159: 1993\u20132000.","journal-title":"J Immunol"},{"key":"1519_CR32","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1073\/pnas.91.7.2752","volume":"91","author":"IF Charo","year":"1994","unstructured":"Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, Coughlin SR. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA 1994, 91: 2752\u20132756.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1519_CR33","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1161\/01.ATV.19.9.2085","volume":"19","author":"KS Weber","year":"1999","unstructured":"Weber KS, Nelson PJ, Gr\u00f6ne HJ, Weber C. Expression of CCR2 by endothelial cells: Implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol 1999, 19: 2085\u20132093.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1519_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13115","volume":"54","author":"M Xu","year":"2021","unstructured":"Xu M, Wang Y, Xia R, Wei Y, Wei X. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting. Cell Prolif 2021, 54: e13115.","journal-title":"Cell Prolif"},{"key":"1519_CR35","doi-asserted-by":"publisher","first-page":"7947","DOI":"10.1073\/pnas.1331358100","volume":"100","author":"C Abbadie","year":"2003","unstructured":"Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci U S A 2003, 100: 7947\u20137952.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1519_CR36","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1523\/JNEUROSCI.3623-08.2009","volume":"29","author":"YJ Gao","year":"2009","unstructured":"Gao YJ, Zhang L, Samad OA, Suter MR, Yasuhiko K, Xu ZZ, et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 2009, 29: 4096\u20134108.","journal-title":"J Neurosci"},{"key":"1519_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12264-012-1218-6","volume":"28","author":"W Guo","year":"2012","unstructured":"Guo W, Wang H, Zou S, Dubner R, Ren K. Chemokine signaling involving chemokine (C-C motif) ligand 2 plays a role in descending pain facilitation. Neurosci Bull 2012, 28: 193\u2013207.","journal-title":"Neurosci Bull"},{"key":"1519_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainres.2008.11.046","volume":"1251","author":"SM Jeon","year":"2009","unstructured":"Jeon SM, Lee KM, Cho HJ. Expression of monocyte chemoattractant protein-1 in rat dorsal root Ganglia and spinal cord in experimental models of neuropathic pain. Brain Res 2009, 1251: 103\u2013111.","journal-title":"Brain Res"},{"key":"1519_CR39","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1007\/s12035-023-03881-z","volume":"61","author":"H Guo","year":"2024","unstructured":"Guo H, Hu WC, Xian H, Shi YX, Liu YY, Ma SB, et al. CCL2 potentiates inflammation pain and related anxiety-like behavior through NMDA signaling in anterior cingulate cortex. Mol Neurobiol 2024, 61: 4976\u20134991.","journal-title":"Mol Neurobiol"},{"key":"1519_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.859558","volume":"15","author":"Y Lu","year":"2022","unstructured":"Lu Y, Li B, Xu A, Liang X, Xu T, Jin H, et al. NF-\u03baB and AP-1 are required for the lipopolysaccharide-induced expression of MCP-1, CXCL1, and Cx43 in cultured rat dorsal spinal cord astrocytes. Front Mol Neurosci 2022, 15: 859558.","journal-title":"Front Mol Neurosci"},{"key":"1519_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12264-017-0106-5","volume":"34","author":"RG Xie","year":"2018","unstructured":"Xie RG, Gao YJ, Park CK, Lu N, Luo C, Wang WT, et al. Spinal CCL2 promotes central sensitization, long-term potentiation, and inflammatory pain via CCR2: Further insights into molecular, synaptic, and cellular mechanisms. Neurosci Bull 2018, 34: 13\u201321.","journal-title":"Neurosci Bull"},{"key":"1519_CR42","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s12264-020-00557-9","volume":"36","author":"H Zhang","year":"2020","unstructured":"Zhang H, Ma SB, Gao YJ, Xing JL, Xian H, Li ZZ, et al. Spinal CCL2 promotes pain sensitization by rapid enhancement of NMDA-induced currents through the ERK-GluN2B pathway in mouse Lamina II neurons. Neurosci Bull 2020, 36: 1344\u20131354.","journal-title":"Neurosci Bull"},{"key":"1519_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13041-020-00701-6","volume":"13","author":"SB Ma","year":"2020","unstructured":"Ma SB, Xian H, Wu WB, Ma SY, Liu YK, Liang YT, et al. CCL2 facilitates spinal synaptic transmission and pain via interaction with presynaptic CCR2 in spinal nociceptor terminals. Mol Brain 2020, 13: 161.","journal-title":"Mol Brain"},{"key":"1519_CR44","first-page":"41","volume":"28","author":"T Ellingsen","year":"2001","unstructured":"Ellingsen T, Buus A, Stengaard-Pedersen K. Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis. J Rheumatol 2001, 28: 41\u201346.","journal-title":"J Rheumatol"},{"key":"1519_CR45","first-page":"641","volume":"110","author":"A Stankovic","year":"2009","unstructured":"Stankovic A, Slavic V, Stamenkovic B, Kamenov B, Bojanovic M, Mitrovic DR. Serum and synovial fluid concentrations of CCL2 (MCP-1) chemokine in patients suffering rheumatoid arthritis and osteoarthritis reflect disease activity. Bratisl Lek Listy 2009, 110: 641\u2013646.","journal-title":"Bratisl Lek Listy"},{"key":"1519_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12974-021-02125-y","volume":"18","author":"MA Dansereau","year":"2021","unstructured":"Dansereau MA, Midavaine \u00c9, B\u00e9gin-Lavall\u00e9e V, Belkouch M, Beaudet N, Longpr\u00e9 JM, et al. Mechanistic insights into the role of the chemokine CCL2\/CCR2 axis in dorsal root Ganglia to peripheral inflammation and pain hypersensitivity. J Neuroinflammation 2021, 18: 79.","journal-title":"J Neuroinflammation"},{"key":"1519_CR47","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1302\/2046-3758.108.BJR-2019-0308.R2","volume":"10","author":"Z Tao","year":"2021","unstructured":"Tao Z, Zhou Y, Zeng B, Yang X, Su M. MicroRNA-183 attenuates osteoarthritic pain by inhibiting the TGF\u03b1-mediated CCL2\/CCR2 signalling axis. Bone Joint Res 2021, 10: 548\u2013557.","journal-title":"Bone Joint Res"},{"key":"1519_CR48","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3892\/ijmm.2016.2763","volume":"38","author":"CH Guo","year":"2016","unstructured":"Guo CH, Bai L, Wu HH, Yang J, Cai GH, Wang X, et al. The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK\/CCL2 pathway in bone cancer pain. Int J Mol Med 2016, 38: 1433\u20131442.","journal-title":"Int J Mol Med"},{"key":"1519_CR49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10571-013-9995-7","volume":"34","author":"M Pevida","year":"2014","unstructured":"Pevida M, Gonz\u00e1lez-Rodr\u00edguez S, Lastra A, Garc\u00eda-Su\u00e1rez O, Hidalgo A, Men\u00e9ndez L, et al. Involvement of spinal chemokine CCL2 in the hyperalgesia evoked by bone cancer in mice: A role for astroglia and microglia. Cell Mol Neurobiol 2014, 34: 143\u2013156.","journal-title":"Cell Mol Neurobiol"},{"key":"1519_CR50","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.neures.2004.01.004","volume":"48","author":"T Tanaka","year":"2004","unstructured":"Tanaka T, Minami M, Nakagawa T, Satoh M. Enhanced production of monocyte chemoattractant protein-1 in the dorsal root Ganglia in a rat model of neuropathic pain: Possible involvement in the development of neuropathic pain. Neurosci Res 2004, 48: 463\u2013469.","journal-title":"Neurosci Res"},{"key":"1519_CR51","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jpain.2014.01.492","volume":"15","author":"X Zhu","year":"2014","unstructured":"Zhu X, Cao S, Zhu MD, Liu JQ, Chen JJ, Gao YJ. Contribution of chemokine CCL2\/CCR2 signaling in the dorsal root ganglion and spinal cord to the maintenance of neuropathic pain in a rat model of lumbar disc herniation. J Pain 2014, 15: 516\u2013526.","journal-title":"J Pain"},{"key":"1519_CR52","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1038\/s44319-024-00133-6","volume":"25","author":"D Sharma","year":"2024","unstructured":"Sharma D, Feng X, Wang B, Yasin B, Bekker A, Hu H, et al. NT-3 contributes to chemotherapy-induced neuropathic pain through TrkC-mediated CCL2 elevation in DRG neurons. EMBO Rep 2024, 25: 2375\u20132390.","journal-title":"EMBO Rep"},{"key":"1519_CR53","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1097\/j.pain.0000000000001212","volume":"159","author":"AM Illias","year":"2018","unstructured":"Illias AM, Gist AC, Zhang H, Kosturakis AK, Dougherty PM. Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity. Pain 2018, 159: 1308\u20131316.","journal-title":"Pain"},{"key":"1519_CR54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12974-022-02497-9","volume":"19","author":"AD Talsma","year":"2022","unstructured":"Talsma AD, Niemi JP, Pachter JS, Zigmond RE. The primary macrophage chemokine, CCL2, is not necessary after a peripheral nerve injury for macrophage recruitment and activation or for conditioning lesion enhanced peripheral regeneration. J Neuroinflammation 2022, 19: 179.","journal-title":"J Neuroinflammation"},{"issue":"Suppl 1","key":"1519_CR55","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.pain.2013.06.022","volume":"154","author":"RR Ji","year":"2013","unstructured":"Ji RR, Berta T, Nedergaard M. Glia and pain: Is chronic pain a gliopathy? Pain 2013, 154(Suppl 1): S10\u2013S28.","journal-title":"Pain"},{"key":"1519_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fonc.2020.00019","volume":"10","author":"T Huang","year":"2020","unstructured":"Huang T, Fan Q, Wang Y, Cui Y, Wang Z, Yang L, et al. Schwann cell-derived CCL2 promotes the perineural invasion of cervical cancer. Front Oncol 2020, 10: 19.","journal-title":"Front Oncol"},{"key":"1519_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104211","volume":"357","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Li J, Han B, Zhong R, Zhong H. Schwann cells promote lung cancer proliferation by promoting the M2 polarization of macrophages. Cell Immunol 2020, 357: 104211.","journal-title":"Cell Immunol"},{"key":"1519_CR58","doi-asserted-by":"publisher","first-page":"205","DOI":"10.21873\/invivo.13427","volume":"38","author":"J Deng","year":"2024","unstructured":"Deng J, Liang J, Cao Y, Tong X, Li H. CCL2- and Notch2-mediated central sensitization in a rat chronic pelvic pain model. In Vivo 2024, 38: 205\u2013212.","journal-title":"In Vivo"},{"key":"1519_CR59","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neuron.2018.08.030","volume":"100","author":"L Duan","year":"2018","unstructured":"Duan L, Zhang XD, Miao WY, Sun YJ, Xiong G, Wu Q, et al. PDGFR\u03b2 cells rapidly relay inflammatory signal from the circulatory system to neurons via chemokine CCL2. Neuron 2018, 100: 183-200.e8.","journal-title":"Neuron"},{"key":"1519_CR60","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuroscience.2019.11.012","volume":"425","author":"H Xian","year":"2020","unstructured":"Xian H, Jiang Y, Zhang H, Ma SB, Zhao R, Cong R. CCL2-CCR2 axis potentiates NMDA receptor signaling to aggravate neuropathic pain induced by brachial plexus avulsion. Neuroscience 2020, 425: 29\u201338.","journal-title":"Neuroscience"},{"key":"1519_CR61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.brainresbull.2019.04.014","volume":"149","author":"S Chun","year":"2019","unstructured":"Chun S, Kwon YB. The CCL2 elevation in primary afferent fibers produces zymosan-induced hyperalgesia through microglia-mediated neuronal activation in the spinal dorsal horn. Brain Res Bull 2019, 149: 53\u201359.","journal-title":"Brain Res Bull"},{"key":"1519_CR62","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1468-2982.2008.01727.x","volume":"29","author":"SH B\u00f8","year":"2009","unstructured":"B\u00f8 SH, Davidsen EM, Gulbrandsen P, Dietrichs E, Bovim G, Stovner LJ, et al. Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia 2009, 29: 365\u2013372.","journal-title":"Cephalalgia"},{"key":"1519_CR63","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1093\/brain\/awad191","volume":"146","author":"S Ryu","year":"2023","unstructured":"Ryu S, Liu X, Guo T, Guo Z, Zhang J, Cao YQ. Peripheral CCL2-CCR2 signalling contributes to chronic headache-related sensitization. Brain 2023, 146: 4274\u20134291.","journal-title":"Brain"},{"key":"1519_CR64","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1038\/s41386-018-0115-8","volume":"43","author":"XB Wu","year":"2018","unstructured":"Wu XB, Jing PB, Zhang ZJ, Cao DL, Gao MH, Jiang BC, et al. Chemokine receptor CCR2 contributes to neuropathic pain and the associated depression via increasing NR2B-mediated currents in both D1 and D2 dopamine receptor-containing medium spiny neurons in the nucleus accumbens shell. Neuropsychopharmacology 2018, 43: 2320\u20132330.","journal-title":"Neuropsychopharmacology"},{"key":"1519_CR65","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fncel.2018.00040","volume":"12","author":"P Dubov\u00fd","year":"2018","unstructured":"Dubov\u00fd P, Klus\u00e1kov\u00e1 I, Hradilov\u00e1-Sv\u00ed\u017eensk\u00e1 I, Joukal M, Boadas-Vaello P. Activation of astrocytes and microglial cells and CCL2\/CCR2 upregulation in the dorsolateral and ventrolateral nuclei of periaqueductal gray and rostral ventromedial medulla following different types of sciatic nerve injury. Front Cell Neurosci 2018, 12: 40.","journal-title":"Front Cell Neurosci"},{"key":"1519_CR66","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.pain.2014.05.031","volume":"155","author":"A Sawada","year":"2014","unstructured":"Sawada A, Niiyama Y, Ataka K, Nagaishi K, Yamakage M, Fujimiya M. Suppression of bone marrow-derived microglia in the amygdala improves anxiety-like behavior induced by chronic partial sciatic nerve ligation in mice. Pain 2014, 155: 1762\u20131772.","journal-title":"Pain"},{"key":"1519_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2023.110801","volume":"205","author":"L Chen","year":"2023","unstructured":"Chen L, Qin Q, Huang P, Cao F, Yin M, Xie Y, et al. Chronic pain accelerates cognitive impairment by reducing hippocampal neurogenesis may via CCL2\/CCR2 signaling in APP\/PS1 mice. Brain Res Bull 2023, 205: 110801.","journal-title":"Brain Res Bull"},{"key":"1519_CR68","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neuroscience.2018.08.010","volume":"390","author":"NT Fiore","year":"2018","unstructured":"Fiore NT, Austin PJ. Glial-cytokine-neuronal adaptations in the ventral hippocampus of rats with affective behavioral changes following peripheral nerve injury. Neuroscience 2018, 390: 119\u2013140.","journal-title":"Neuroscience"},{"key":"1519_CR69","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1742-2094-9-136","volume":"9","author":"ZJ Zhang","year":"2012","unstructured":"Zhang ZJ, Dong YL, Lu Y, Cao S, Zhao ZQ, Gao YJ. Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain. J Neuroinflammation 2012, 9: 136.","journal-title":"J Neuroinflammation"},{"key":"1519_CR70","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/14728222.2017.1328057","volume":"21","author":"T Berta","year":"2017","unstructured":"Berta T, Qadri Y, Tan PH, Ji RR. Targeting dorsal root Ganglia and primary sensory neurons for the treatment of chronic pain. Expert Opin Ther Targets 2017, 21: 695\u2013703.","journal-title":"Expert Opin Ther Targets"},{"key":"1519_CR71","doi-asserted-by":"publisher","first-page":"1144614","DOI":"10.3389\/fnmol.2023.1144614","volume":"16","author":"L Li","year":"2023","unstructured":"Li L, Liu Y, Hu W, Yang J, Ma S, Tian Z, et al. Peripheral CCL2 induces inflammatory pain via regulation of Ih currents in small diameter DRG neurons. Front Mol Neurosci 2023, 16: 1144614.","journal-title":"Front Mol Neurosci"},{"key":"1519_CR72","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/14728222.2023.2247563","volume":"27","author":"T Berta","year":"2023","unstructured":"Berta T, Strong JA, Zhang JM, Ji RR. Targeting dorsal root Ganglia and primary sensory neurons for the treatment of chronic pain: An update. Expert Opin Ther Targets 2023, 27: 665\u2013678.","journal-title":"Expert Opin Ther Targets"},{"key":"1519_CR73","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/pm\/pnz012","volume":"20","author":"MF Esposito","year":"2019","unstructured":"Esposito MF, Malayil R, Hanes M, Deer T. Unique characteristics of the dorsal root ganglion as a target for neuromodulation. Pain Med 2019, 20: S23\u2013S30.","journal-title":"Pain Med"},{"key":"1519_CR74","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11916-017-0629-5","volume":"21","author":"K Meacham","year":"2017","unstructured":"Meacham K, Shepherd A, Mohapatra DP, Haroutounian S. Neuropathic pain: Central vs. peripheral mechanisms. Curr Pain Headache Rep 2017, 21: 28.","journal-title":"Curr Pain Headache Rep"},{"key":"1519_CR75","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jpain.2013.03.012","volume":"14","author":"H Zhang","year":"2013","unstructured":"Zhang H, Boyette-Davis JA, Kosturakis AK, Li Y, Yoon SY, Walters ET, et al. Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy. J Pain 2013, 14: 1031\u20131044.","journal-title":"J Pain"},{"key":"1519_CR76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.conb.2019.11.006","volume":"62","author":"C Ouyang","year":"2020","unstructured":"Ouyang C, Donnelly CR, Ji RR. Regulation of pain by neuro-immune interactions between macrophages and nociceptor sensory neurons. Curr Opin Neurobiol 2020, 62: 17\u201325.","journal-title":"Curr Opin Neurobiol"},{"key":"1519_CR77","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","volume":"38","author":"FA Pinho-Ribeiro","year":"2017","unstructured":"Pinho-Ribeiro FA, Verri WA, Chiu IM. Nociceptor sensory neuron\u2013immune interactions in pain and inflammation. Trends Immunol 2017, 38: 5\u201319.","journal-title":"Trends Immunol"},{"key":"1519_CR78","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13020-024-01023-8","volume":"20","author":"Y Li","year":"2025","unstructured":"Li Y, Xu R, Chen M, Zheng K, Nie H, Yin C, et al. Electroacupuncture alleviates paclitaxel-induced peripheral neuropathy by reducing CCL2-mediated macrophage infiltration in sensory Ganglia and sciatic nerve. Chin Med 2025, 20: 9.","journal-title":"Chin Med"},{"key":"1519_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/14728222.2019.1550075","volume":"23","author":"S Wu","year":"2019","unstructured":"Wu S, Bono J, Tao YX. Long noncoding RNA (lncRNA): A target in neuropathic pain. Expert Opin Ther Targets 2019, 23: 15\u201320.","journal-title":"Expert Opin Ther Targets"},{"key":"1519_CR80","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153563","volume":"132","author":"S Du","year":"2022","unstructured":"Du S, Wu S, Feng X, Wang B, Xia S, Liang L, et al. A nerve injury-specific long noncoding RNA promotes neuropathic pain by increasing Ccl2 expression. J Clin Invest 2022, 132: e153563.","journal-title":"J Clin Invest"},{"key":"1519_CR81","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1744-8069-7-74","volume":"7","author":"D Kim","year":"2011","unstructured":"Kim D, You B, Lim H, Lee SJ. Toll-like receptor 2 contributes to chemokine gene expression and macrophage infiltration in the dorsal root Ganglia after peripheral nerve injury. Mol Pain 2011, 7: 74.","journal-title":"Mol Pain"},{"key":"1519_CR82","first-page":"3709","volume":"42","author":"QY Li","year":"2017","unstructured":"Li QY, Xu HY, Yang HJ. Effect of proinflammatory factors TNF-\u03b1, IL-1\u03b2, IL-6 on neuropathic pain. Zhongguo Zhong Yao Za Zhi 2017, 42: 3709\u20133712.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"1519_CR83","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.aaf8924","volume":"354","author":"RR Ji","year":"2016","unstructured":"Ji RR, Chamessian A, Zhang YQ. Pain regulation by non-neuronal cells and inflammation. Science 2016, 354: 572\u2013577.","journal-title":"Science"},{"key":"1519_CR84","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/molecules21060797","volume":"21","author":"B Frias","year":"2016","unstructured":"Frias B, Merighi A. Capsaicin, nociception and pain. Molecules 2016, 21: 797.","journal-title":"Molecules"},{"key":"1519_CR85","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1073\/pnas.97.7.3655","volume":"97","author":"E Mezey","year":"2000","unstructured":"Mezey E, T\u00f3th ZE, Cortright DN, Arzubi MK, Krause JE, Elde R, et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A 2000, 97: 3655\u20133660.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1519_CR86","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2174\/1874467210801030255","volume":"1","author":"A Jara-Oseguera","year":"2008","unstructured":"Jara-Oseguera A, Simon SA, Rosenbaum T. TRPV1: On the road to pain relief. Curr Mol Pharmacol 2008, 1: 255\u2013269.","journal-title":"Curr Mol Pharmacol"},{"key":"1519_CR87","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1126\/science.288.5464.306","volume":"288","author":"MJ Caterina","year":"2000","unstructured":"Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288: 306\u2013313.","journal-title":"Science"},{"key":"1519_CR88","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1744-8069-4-61","volume":"4","author":"L Yu","year":"2008","unstructured":"Yu L, Yang F, Luo H, Liu FY, Han JS, Xing GG, et al. The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund\u2019s adjuvant. Mol Pain 2008, 4: 61.","journal-title":"Mol Pain"},{"key":"1519_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176845","volume":"980","author":"A Dangi","year":"2024","unstructured":"Dangi A, Sharma SS. Pharmacological agents targeting transient receptor potential (TRP) channels in neuropathic pain: Preclinical and clinical status. Eur J Pharmacol 2024, 980: 176845.","journal-title":"Eur J Pharmacol"},{"key":"1519_CR90","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pain.2007.06.006","volume":"132","author":"BA Chizh","year":"2007","unstructured":"Chizh BA, O\u2019Donnell MB, Napolitano A, Wang J, Brooke AC, Aylott MC, et al. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain 2007, 132: 132\u2013141.","journal-title":"Pain"},{"key":"1519_CR91","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/1742-2094-9-189","volume":"9","author":"DJ Kao","year":"2012","unstructured":"Kao DJ, Li AH, Chen JC, Luo RS, Chen YL, Lu JC, et al. CC chemokine ligand 2 upregulates the current density and expression of TRPV1 channels and Nav1.8 sodium channels in dorsal root ganglion neurons. J Neuroinflammation 2012, 9: 189.","journal-title":"J Neuroinflammation"},{"key":"1519_CR92","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.1523\/JNEUROSCI.5986-10.2011","volume":"31","author":"J Van Steenwinckel","year":"2011","unstructured":"Van Steenwinckel J, Reaux-Le Goazigo A, Pommier B, Mauborgne A, Dansereau MA, Kitabgi P, et al. CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. J Neurosci 2011, 31: 5865\u20135875.","journal-title":"J Neurosci"},{"key":"1519_CR93","doi-asserted-by":"publisher","first-page":"14092","DOI":"10.1073\/pnas.0503496102","volume":"102","author":"FA White","year":"2005","unstructured":"White FA, Sun J, Waters SM, Ma C, Ren D, Ripsch M, et al. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci U S A 2005, 102: 14092\u201314097.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1519_CR94","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuropharm.2014.01.041","volume":"81","author":"D Spicarova","year":"2014","unstructured":"Spicarova D, Adamek P, Kalynovska N, Mrozkova P, Palecek J. TRPV1 receptor inhibition decreases CCL2-induced hyperalgesia. Neuropharmacology 2014, 81: 75\u201384.","journal-title":"Neuropharmacology"},{"key":"1519_CR95","doi-asserted-by":"publisher","first-page":"7188","DOI":"10.1038\/s41598-018-24056-0","volume":"8","author":"JM Rosen","year":"2018","unstructured":"Rosen JM, Yaggie RE, Woida PJ, Miller RJ, Schaeffer AJ, Klumpp DJ. TRPV1 and the MCP-1\/CCR2 axis modulate post-UTI chronic pain. Sci Rep 2018, 8: 7188.","journal-title":"Sci Rep"},{"key":"1519_CR96","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0896-6273(02)00802-4","volume":"35","author":"G Bhave","year":"2002","unstructured":"Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RW 4th. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 2002, 35: 721\u2013731.","journal-title":"Neuron"},{"key":"1519_CR97","doi-asserted-by":"publisher","first-page":"13424","DOI":"10.1074\/jbc.M410917200","volume":"280","author":"DP Mohapatra","year":"2005","unstructured":"Mohapatra DP, Nau C. Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase. J Biol Chem 2005, 280: 13424\u201313432.","journal-title":"J Biol Chem"},{"key":"1519_CR98","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/35050121","volume":"408","author":"LS Premkumar","year":"2000","unstructured":"Premkumar LS, Ahern GP. Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000, 408: 985\u2013990.","journal-title":"Nature"},{"key":"1519_CR99","doi-asserted-by":"publisher","first-page":"13375","DOI":"10.1074\/jbc.C200104200","volume":"277","author":"M Numazaki","year":"2002","unstructured":"Numazaki M, Tominaga T, Toyooka H, Tominaga M. Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J Biol Chem 2002, 277: 13375\u201313378.","journal-title":"J Biol Chem"},{"key":"1519_CR100","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12264-012-1211-0","volume":"28","author":"Y Han","year":"2012","unstructured":"Han Y, Li Y, Xiao X, Liu J, Meng XL, Liu FY, et al. Formaldehyde up-regulates TRPV1 through MAPK and PI3K signaling pathways in a rat model of bone cancer pain. Neurosci Bull 2012, 28: 165\u2013172.","journal-title":"Neurosci Bull"},{"key":"1519_CR101","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1113\/jphysiol.2003.039990","volume":"551","author":"JK Bonnington","year":"2003","unstructured":"Bonnington JK, McNaughton PA. Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J Physiol 2003, 551: 433\u2013446.","journal-title":"J Physiol"},{"key":"1519_CR102","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/cns.13303","volume":"26","author":"BY Zhang","year":"2020","unstructured":"Zhang BY, Zhang YL, Sun Q, Zhang PA, Wang XX, Xu GY, et al. Alpha-lipoic acid downregulates TRPV1 receptor via NF-\u03baB and attenuates neuropathic pain in rats with diabetes. CNS Neurosci Ther 2020, 26: 762\u2013772.","journal-title":"CNS Neurosci Ther"},{"key":"1519_CR103","first-page":"1191","volume":"13","author":"R Barbieri","year":"2023","unstructured":"Barbieri R, Nizzari M, Zanardi I, Pusch M, Gavazzo P. Voltage-gated sodium channel dysfunctions in neurological disorders. Life (Basel) 2023, 13: 1191.","journal-title":"Life (Basel)"},{"key":"1519_CR104","doi-asserted-by":"publisher","first-page":"174480691985880","DOI":"10.1177\/1744806919858801","volume":"15","author":"S Hameed","year":"2019","unstructured":"Hameed S. Nav1.7 and Nav1.8: Role in the pathophysiology of pain. Mol Pain 2019, 15: 1744806919858801.","journal-title":"Mol Pain"},{"key":"1519_CR105","doi-asserted-by":"crossref","unstructured":"Kingwell K. Nav1.7 withholds its pain potential. Nat Rev Drug Discov 2019.","DOI":"10.1038\/d41573-019-00065-0"},{"key":"1519_CR106","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.2147\/JPR.S207610","volume":"12","author":"RSY Ma","year":"2019","unstructured":"Ma RSY, Kayani K, Whyte-Oshodi D, Whyte-Oshodi A, Nachiappan N, Gnanarajah S, et al. Voltage gated sodium channels as therapeutic targets for chronic pain. J Pain Res 2019, 12: 2709\u20132722.","journal-title":"J Pain Res"},{"key":"1519_CR107","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0304-3959(01)00391-8","volume":"95","author":"J Lai","year":"2002","unstructured":"Lai J, Gold MS, Kim CS, Bian D, Ossipov MH, Hunter JC, et al. Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8. Pain 2002, 95: 143\u2013152.","journal-title":"Pain"},{"key":"1519_CR108","doi-asserted-by":"publisher","first-page":"18381","DOI":"10.1523\/JNEUROSCI.3386-11.2011","volume":"31","author":"M Belkouch","year":"2011","unstructured":"Belkouch M, Dansereau MA, R\u00e9aux-Le Goazigo A, Van Steenwinckel J, Beaudet N, Chraibi A, et al. The chemokine CCL2 increases Nav1.8 sodium channel activity in primary sensory neurons through a G\u03b2\u03b3-dependent mechanism. J Neurosci 2011, 31: 18381\u201318390.","journal-title":"J Neurosci"},{"key":"1519_CR109","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20140005","volume":"34","author":"R Zhao","year":"2014","unstructured":"Zhao R, Pei GX, Cong R, Zhang H, Zang CW, Tian T. PKC-NF-\u03baB are involved in CCL2-induced Nav1.8 expression and channel function in dorsal root ganglion neurons. Biosci Rep 2014, 34: e00111.","journal-title":"Biosci Rep"},{"key":"1519_CR110","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1517\/14728222.2016.1162295","volume":"20","author":"EC Emery","year":"2016","unstructured":"Emery EC, Luiz AP, Wood JN. Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief. Expert Opin Ther Targets 2016, 20: 975\u2013983.","journal-title":"Expert Opin Ther Targets"},{"key":"1519_CR111","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/abbs\/gmy123","volume":"50","author":"P Luo","year":"2018","unstructured":"Luo P, Shao J, Jiao Y, Yu W, Rong W. CC chemokine ligand 2 (CCL2) enhances TTX-sensitive sodium channel activity of primary afferent neurons in the complete Freud adjuvant-induced inflammatory pain model. Acta Biochim Biophys Sin (Shanghai) 2018, 50: 1219\u20131226.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1519_CR112","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/31255","volume":"393","author":"A Ludwig","year":"1998","unstructured":"Ludwig A, Zong X, Jeglitsch M, Hofmann F, Biel M. A family of hyperpolarization-activated mammalian cation channels. Nature 1998, 393: 587\u2013591.","journal-title":"Nature"},{"key":"1519_CR113","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00424-020-02384-3","volume":"472","author":"I Rivolta","year":"2020","unstructured":"Rivolta I, Binda A, Masi A, DiFrancesco JC. Cardiac and neuronal HCN channelopathies. Pflugers Arch 2020, 472: 931\u2013951.","journal-title":"Pflugers Arch"},{"key":"1519_CR114","first-page":"423","volume":"66","author":"T Wu","year":"2014","unstructured":"Wu T, Liu H, Zhang LC. HCN ion channel: Biological characteristics and functions in pain. Acta Physiol Sin 2014, 66: 423\u2013430.","journal-title":"Acta Physiol Sin"},{"key":"1519_CR115","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1523\/JNEUROSCI.5156-03.2004","volume":"24","author":"TN Doan","year":"2004","unstructured":"Doan TN, Stephans K, Ramirez AN, Glazebrook PA, Andresen MC, Kunze DL. Differential distribution and function of hyperpolarization-activated channels in sensory neurons and mechanosensitive fibers. J Neurosci 2004, 24: 3335\u20133343.","journal-title":"J Neurosci"},{"key":"1519_CR116","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1111\/j.1460-9568.2006.05065.x","volume":"24","author":"J Kitagawa","year":"2006","unstructured":"Kitagawa J, Takeda M, Suzuki I, Kadoi J, Tsuboi Y, Honda K, et al. Mechanisms involved in modulation of trigeminal primary afferent activity in rats with peripheral mononeuropathy. Eur J Neurosci 2006, 24: 1976\u20131986.","journal-title":"Eur J Neurosci"},{"key":"1519_CR117","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1212\/WNL.0b013e31827dec42","volume":"80","author":"EE Benarroch","year":"2013","unstructured":"Benarroch EE. HCN channels: Function and clinical implications. Neurology 2013, 80: 304\u2013310.","journal-title":"Neurology"},{"key":"1519_CR118","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/19336950.2020.1870086","volume":"15","author":"LR Jansen","year":"2021","unstructured":"Jansen LR, Forster LA, Smith XL, Rubaharan M, Murphy AZ, Baro DJ. Changes in peripheral HCN2 channels during persistent inflammation. Channels (Austin) 2021, 15: 165\u2013179.","journal-title":"Channels (Austin)"},{"key":"1519_CR119","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s12264-022-00989-5","volume":"39","author":"Y Yan","year":"2023","unstructured":"Yan Y, Zhu M, Cao X, Xu G, Shen W, Li F, et al. Thalamocortical circuit controls neuropathic pain via up-regulation of HCN2 in the ventral posterolateral thalamus. Neurosci Bull 2023, 39: 774\u2013792.","journal-title":"Neurosci Bull"},{"key":"1519_CR120","first-page":"154","volume":"12","author":"H Huang","year":"2019","unstructured":"Huang H, Zhang Z, Huang D. Decreased HCN2 channel expression attenuates neuropathic pain by inhibiting pro-inflammatory reactions and NF-\u03baB activation in mice. Int J Clin Exp Pathol 2019, 12: 154\u2013163.","journal-title":"Int J Clin Exp Pathol"},{"key":"1519_CR121","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1152\/physrev.00059.2021","volume":"103","author":"AF Russo","year":"2023","unstructured":"Russo AF, Hay DL. CGRP physiology, pharmacology, and therapeutic targets: Migraine and beyond. Physiol Rev 2023, 103: 1565\u20131644.","journal-title":"Physiol Rev"},{"key":"1519_CR122","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/bph.15605","volume":"179","author":"TA Rees","year":"2022","unstructured":"Rees TA, Hendrikse ER, Hay DL, Walker CS. Beyond CGRP: The calcitonin peptide family as targets for migraine and pain. Br J Pharmacol 2022, 179: 381\u2013399.","journal-title":"Br J Pharmacol"},{"key":"1519_CR123","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev-pharmtox-010814-124701","volume":"55","author":"AF Russo","year":"2015","unstructured":"Russo AF. Calcitonin gene-related peptide (CGRP): A new target for migraine. Annu Rev Pharmacol Toxicol 2015, 55: 533\u2013552.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1519_CR124","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s10194-017-0807-1","volume":"18","author":"M Deen","year":"2017","unstructured":"Deen M, Correnti E, Kamm K, Kelderman T, Papetti L, Rubio-Beltr\u00e1n E, et al. Blocking CGRP in migraine patients - a review of pros and cons. J Headache Pain 2017, 18: 96.","journal-title":"J Headache Pain"},{"key":"1519_CR125","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","volume":"14","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Haanes KA, Warfvinge K, Krause DN. CGRP as the target of new migraine therapies\u2014successful translation from bench to clinic. Nat Rev Neurol 2018, 14: 338\u2013350.","journal-title":"Nat Rev Neurol"},{"key":"1519_CR126","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1017\/S1740925X12000026","volume":"7","author":"JT Malon","year":"2011","unstructured":"Malon JT, Maddula S, Bell H, Cao L. Involvement of calcitonin gene-related peptide and CCL2 production in CD40-mediated behavioral hypersensitivity in a model of neuropathic pain. Neuron Glia Biol 2011, 7: 117\u2013128.","journal-title":"Neuron Glia Biol"},{"key":"1519_CR127","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3760\/cma.j.issn.0366-6999.2010.13.025","volume":"123","author":"N Han","year":"2010","unstructured":"Han N, Zhang DY, Wang TB, Zhang PX, Jiang BG. Calcitonin gene-related peptide induces proliferation and monocyte chemoattractant protein-1 expression via extracellular signal-regulated kinase activation in rat osteoblasts. Chin Med J (Engl) 2010, 123: 1748\u20131753.","journal-title":"Chin Med J (Engl)"},{"key":"1519_CR128","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.3390\/cells11213498","volume":"11","author":"L Nie","year":"2022","unstructured":"Nie L, Sun K, Gong Z, Li H, Quinn JP, Wang M. Src family kinases facilitate the crosstalk between CGRP and cytokines in sensitizing trigeminal ganglion via transmitting CGRP receptor\/PKA pathway. Cells 2022, 11: 3498.","journal-title":"Cells"},{"key":"1519_CR129","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/jnr.20612","volume":"82","author":"X Qin","year":"2005","unstructured":"Qin X, Wan Y, Wang X. CCL2 and CXCL1 trigger calcitonin gene-related peptide release by exciting primary nociceptive neurons. J Neurosci Res 2005, 82: 51\u201362.","journal-title":"J Neurosci Res"},{"key":"1519_CR130","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s10194-024-01900-5","volume":"25","author":"S Ryu","year":"2024","unstructured":"Ryu S, Zhang J, Simoes R, Liu X, Guo Z, Feng L, et al. Regulatory T cells require peripheral CCL2-CCR2 signaling to facilitate the resolution of medication overuse headache-related behavioral sensitization. J Headache Pain 2024, 25: 197.","journal-title":"J Headache Pain"},{"key":"1519_CR131","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ejpain.2008.04.017","volume":"13","author":"MA Thacker","year":"2009","unstructured":"Thacker MA, Clark AK, Bishop T, Grist J, Yip PK, Moon LDF, et al. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain 2009, 13: 263\u2013272.","journal-title":"Eur J Pain"},{"key":"1519_CR132","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1002\/art.39291","volume":"67","author":"RE Miller","year":"2015","unstructured":"Miller RE, Belmadani A, Ishihara S, Tran PB, Ren D, Miller RJ, et al. Damage-associated molecular patterns generated in osteoarthritis directly excite murine nociceptive neurons through Toll-like receptor 4. Arthritis Rheumatol 2015, 67: 2933\u20132943.","journal-title":"Arthritis Rheumatol"},{"key":"1519_CR133","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pharmthera.2010.01.002","volume":"126","author":"YJ Gao","year":"2010","unstructured":"Gao YJ, Ji RR. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther 2010, 126: 56\u201368.","journal-title":"Pharmacol Ther"},{"key":"1519_CR134","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","volume":"129","author":"RR Ji","year":"2018","unstructured":"Ji RR, Nackley A, Huh Y, Terrando N, Maixner W. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology 2018, 129: 343\u2013366.","journal-title":"Anesthesiology"},{"key":"1519_CR135","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3949\/ccjm.90a.22019","volume":"90","author":"MM Volcheck","year":"2023","unstructured":"Volcheck MM, Graham SM, Fleming KC, Mohabbat AB, Luedtke CA. Central sensitization, chronic pain, and other symptoms: Better understanding, better management. Cleve Clin J Med 2023, 90: 245\u2013254.","journal-title":"Cleve Clin J Med"},{"key":"1519_CR136","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neuropharm.2016.08.014","volume":"112","author":"M Zhuo","year":"2017","unstructured":"Zhuo M. Ionotropic glutamate receptors contribute to pain transmission and chronic pain. Neuropharmacology 2017, 112: 228\u2013234.","journal-title":"Neuropharmacology"},{"key":"1519_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108539","volume":"251","author":"RG Xie","year":"2023","unstructured":"Xie RG, Xu GY, Wu SX, Luo C. Presynaptic glutamate receptors in nociception. Pharmacol Ther 2023, 251: 108539.","journal-title":"Pharmacol Ther"},{"key":"1519_CR138","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.3390\/nu12082184","volume":"12","author":"HJ Shin","year":"2020","unstructured":"Shin HJ, Na HS, Do SH. Magnesium and pain. Nutrients 2020, 12: 2184.","journal-title":"Nutrients"},{"key":"1519_CR139","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1213\/01.ANE.0000081061.12235.55","volume":"97","author":"AB Petrenko","year":"2003","unstructured":"Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-D-aspartate (NMDA) receptors in pain: A review. Anesth Analg 2003, 97: 1108\u20131116.","journal-title":"Anesth Analg"},{"key":"1519_CR140","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1152\/physrev.00034.2022","volume":"103","author":"RA Nicoll","year":"2023","unstructured":"Nicoll RA, Schulman H. Synaptic memory and CaMKII. Physiol Rev 2023, 103: 2877\u20132925.","journal-title":"Physiol Rev"},{"key":"1519_CR141","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11064-018-2614-8","volume":"44","author":"XH Li","year":"2019","unstructured":"Li XH, Miao HH, Zhuo M. NMDA receptor dependent long-term potentiation in chronic pain. Neurochem Res 2019, 44: 531\u2013538.","journal-title":"Neurochem Res"},{"key":"1519_CR142","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s12264-021-00697-6","volume":"37","author":"XB Wu","year":"2021","unstructured":"Wu XB, Zhu Q, Gao YJ. CCL2\/CCR2 contributes to the altered excitatory-inhibitory synaptic balance in the nucleus accumbens shell following peripheral nerve injury-induced neuropathic pain. Neurosci Bull 2021, 37: 921\u2013933.","journal-title":"Neurosci Bull"},{"key":"1519_CR143","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.semcdb.2011.06.003","volume":"22","author":"S Qiu","year":"2011","unstructured":"Qiu S, Li XY, Zhuo M. Post-translational modification of NMDA receptor GluN2B subunit and its roles in chronic pain and memory. Semin Cell Dev Biol 2011, 22: 521\u2013529.","journal-title":"Semin Cell Dev Biol"},{"key":"1519_CR144","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.nurt.2009.07.008","volume":"6","author":"LJ Wu","year":"2009","unstructured":"Wu LJ, Zhuo M. Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain. Neurotherapeutics 2009, 6: 693\u2013702.","journal-title":"Neurotherapeutics"},{"key":"1519_CR145","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1744-8069-7-8","volume":"7","author":"Y Mihara","year":"2011","unstructured":"Mihara Y, Egashira N, Sada H, Kawashiri T, Ushio S, Yano T, et al. Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats. Mol Pain 2011, 7: 8.","journal-title":"Mol Pain"},{"key":"1519_CR146","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.nbd.2014.10.025","volume":"73","author":"X Ding","year":"2015","unstructured":"Ding X, Cai J, Li S, Liu XD, Wan Y, Xing GG. BDNF contributes to the development of neuropathic pain by induction of spinal long-term potentiation via SHP2 associated GluN2B-containing NMDA receptors activation in rats with spinal nerve ligation. Neurobiol Dis 2015, 73: 428\u2013451.","journal-title":"Neurobiol Dis"},{"key":"1519_CR147","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.neuron.2018.11.009","volume":"100","author":"G Chen","year":"2018","unstructured":"Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR. Microglia in pain: Detrimental and protective roles in pathogenesis and resolution of pain. Neuron 2018, 100: 1292\u20131311.","journal-title":"Neuron"},{"key":"1519_CR148","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/1073858409360822","volume":"16","author":"RD Gosselin","year":"2010","unstructured":"Gosselin RD, Suter MR, Ji RR, Decosterd I. Glial cells and chronic pain. Neuroscientist 2010, 16: 519\u2013531.","journal-title":"Neuroscientist"},{"key":"1519_CR149","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s12264-022-00961-3","volume":"39","author":"HJ Lu","year":"2023","unstructured":"Lu HJ, Gao YJ. Astrocytes in chronic pain: Cellular and molecular mechanisms. Neurosci Bull 2023, 39: 425\u2013439.","journal-title":"Neurosci Bull"},{"key":"1519_CR150","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nurt.2010.05.016","volume":"7","author":"YJ Gao","year":"2010","unstructured":"Gao YJ, Ji RR. Targeting astrocyte signaling for chronic pain. Neurotherapeutics 2010, 7: 482\u2013493.","journal-title":"Neurotherapeutics"},{"key":"1519_CR151","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.brainresrev.2008.12.002","volume":"60","author":"C Abbadie","year":"2009","unstructured":"Abbadie C, Bhangoo S, De Koninck Y, Malcangio M, Melik-Parsadaniantz S, White FA. Chemokines and pain mechanisms. Brain Res Rev 2009, 60: 125\u2013134.","journal-title":"Brain Res Rev"},{"key":"1519_CR152","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3390\/cells10051124","volume":"10","author":"R Franco","year":"2021","unstructured":"Franco R, Lillo A, Rivas-Santisteban R, Reyes-Resina I, Navarro G. Microglial adenosine receptors: From preconditioning to modulating the M1\/M2 balance in activated cells. Cells 2021, 10: 1124.","journal-title":"Cells"},{"key":"1519_CR153","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fncel.2020.00198","volume":"14","author":"AM Jurga","year":"2020","unstructured":"Jurga AM, Paleczna M, Kuter KZ. Overview of general and discriminating markers of differential microglia phenotypes. Front Cell Neurosci 2020, 14: 198.","journal-title":"Front Cell Neurosci"},{"key":"1519_CR154","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela R, McPherson CA, Harry GJ. Microglial M1\/M2 polarization and metabolic states. Br J Pharmacol 2016, 173: 649\u2013665.","journal-title":"Br J Pharmacol"},{"key":"1519_CR155","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2016.04.001","volume":"163","author":"HO Kalkman","year":"2016","unstructured":"Kalkman HO, Feuerbach D. Antidepressant therapies inhibit inflammation and microglial M1-polarization. Pharmacol Ther 2016, 163: 82\u201393.","journal-title":"Pharmacol Ther"},{"key":"1519_CR156","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/WNR.0b013e32834cd76a","volume":"22","author":"T Komori","year":"2011","unstructured":"Komori T, Morikawa Y, Inada T, Hisaoka T, Senba E. Site-specific subtypes of macrophages recruited after peripheral nerve injury. Neuroreport 2011, 22: 911\u2013917.","journal-title":"Neuroreport"},{"key":"1519_CR157","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10787-023-01216-x","volume":"31","author":"AA Atta","year":"2023","unstructured":"Atta AA, Ibrahim WW, Mohamed AF, Abdelkader NF. Microglia polarization in nociplastic pain: Mechanisms and perspectives. Inflammopharmacology 2023, 31: 1053\u20131067.","journal-title":"Inflammopharmacology"},{"key":"1519_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2020.101671","volume":"54","author":"K Popiolek-Barczyk","year":"2020","unstructured":"Popiolek-Barczyk K, Ciechanowska A, Ciapa\u0142a K, Pawlik K, Oggioni M, Mercurio D, et al. The CCL2\/CCL7\/CCL12\/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia. Mol Cell Probes 2020, 54: 101671.","journal-title":"Mol Cell Probes"},{"key":"1519_CR159","doi-asserted-by":"publisher","first-page":"1191188","DOI":"10.3389\/fimmu.2023.1191188","volume":"14","author":"Q Li","year":"2023","unstructured":"Li Q, Yang Z, Wang K, Chen Z, Shen H. Suppression of microglial Ccl2 reduces neuropathic pain associated with chronic spinal compression. Front Immunol 2023, 14: 1191188.","journal-title":"Front Immunol"},{"key":"1519_CR160","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.brainresbull.2013.03.005","volume":"95","author":"M Pevida","year":"2013","unstructured":"Pevida M, Lastra A, Hidalgo A, Baamonde A, Men\u00e9ndez L. Spinal CCL2 and microglial activation are involved in paclitaxel-evoked cold hyperalgesia. Brain Res Bull 2013, 95: 21\u201327.","journal-title":"Brain Res Bull"},{"key":"1519_CR161","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3390\/ph16071023","volume":"16","author":"R Zaj\u0105czkowska","year":"2023","unstructured":"Zaj\u0105czkowska R, Pawlik K, Ciapa\u0142a K, Piotrowska A, Ciechanowska A, Rojewska E, et al. Mirogabalin decreases pain-like behaviors by inhibiting the microglial\/macrophage activation, p38MAPK signaling, and pronociceptive CCL2 and CCL5 release in a mouse model of neuropathic pain. Pharmaceuticals (Basel) 2023, 16: 1023.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1519_CR162","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000528450","volume":"45","author":"X Jin","year":"2023","unstructured":"Jin X, Zheng W, Chi S, Cui T, He W. miR-506-3p relieves neuropathic pain following brachial plexus avulsion via mitigating microglial activation through targeting the CCL2-CCR2 axis. Dev Neurosci 2023, 45: 37\u201352.","journal-title":"Dev Neurosci"},{"key":"1519_CR163","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nature01786","volume":"424","author":"M Tsuda","year":"2003","unstructured":"Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424: 778\u2013783.","journal-title":"Nature"},{"key":"1519_CR164","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11302-011-9288-x","volume":"8","author":"E Toyomitsu","year":"2012","unstructured":"Toyomitsu E, Tsuda M, Yamashita T, Tozaki-Saitoh H, Tanaka Y, Inoue K. CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia. Purinergic Signal 2012, 8: 301\u2013310.","journal-title":"Purinergic Signal"},{"key":"1519_CR165","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neulet.2019.02.024","volume":"701","author":"Y Yan","year":"2019","unstructured":"Yan Y, Liang Y, Ding T, Chu H. PI3K\/Akt signaling pathway may be involved in MCP-1-induced P2X4R expression in cultured microglia and cancer-induced bone pain rats. Neurosci Lett 2019, 701: 100\u2013105.","journal-title":"Neurosci Lett"},{"key":"1519_CR166","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.brainres.2014.12.043","volume":"1599","author":"D Jin","year":"2015","unstructured":"Jin D, Yang JP, Hu JH, Wang LN, Zuo JL. MCP-1 stimulates spinal microglia via PI3K\/Akt pathway in bone cancer pain. Brain Res 2015, 1599: 158\u2013167.","journal-title":"Brain Res"},{"key":"1519_CR167","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1523\/JNEUROSCI.3338-07.2008","volume":"28","author":"Y Kawasaki","year":"2008","unstructured":"Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: Distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008, 28: 5189\u20135194.","journal-title":"J Neurosci"},{"key":"1519_CR168","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/glia.21056","volume":"58","author":"YJ Gao","year":"2010","unstructured":"Gao YJ, Zhang L, Ji RR. Spinal injection of TNF-\u03b1-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1. Glia 2010, 58: 1871\u20131880.","journal-title":"Glia"},{"key":"1519_CR169","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pain.2009.02.006","volume":"143","author":"DS Kim","year":"2009","unstructured":"Kim DS, Figueroa KW, Li KW, Boroujerdi A, Yolo T, David Luo Z. Profiling of dynamically changed gene expression in dorsal root Ganglia post peripheral nerve injury and a critical role of injury-induced glial fibrillary acidic protein in maintenance of pain behaviors [corrected. Pain 2009, 143: 114\u2013122.","journal-title":"Pain"},{"key":"1519_CR170","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1007\/s00018-017-2513-1","volume":"74","author":"ZJ Zhang","year":"2017","unstructured":"Zhang ZJ, Jiang BC, Gao YJ. Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain. Cell Mol Life Sci 2017, 74: 3275\u20133291.","journal-title":"Cell Mol Life Sci"},{"key":"1519_CR171","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jcp.24452","volume":"229","author":"N Morioka","year":"2014","unstructured":"Morioka N, Abe H, Araki R, Matsumoto N, Zhang FF, Nakamura Y, et al. A \u03b21\/2 adrenergic receptor-sensitive intracellular signaling pathway modulates CCL2 production in cultured spinal astrocytes. J Cell Physiol 2014, 229: 323\u2013332.","journal-title":"J Cell Physiol"},{"key":"1519_CR172","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073948","volume":"8","author":"JY Lee","year":"2013","unstructured":"Lee JY, Choi DC, Oh TH, Yune TY. Analgesic effect of acupuncture is mediated via inhibition of JNK activation in astrocytes after spinal cord injury. PLoS One 2013, 8: e73948.","journal-title":"PLoS One"},{"key":"1519_CR173","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brainres.2009.06.081","volume":"1287","author":"WL Thompson","year":"2009","unstructured":"Thompson WL, Van Eldik LJ. Inflammatory cytokines stimulate the chemokines CCL2\/MCP-1 and CCL7\/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes [corrected. Brain Res 2009, 1287: 47\u201357.","journal-title":"Brain Res"},{"key":"1519_CR174","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbi.2023.11.035","volume":"116","author":"B He","year":"2024","unstructured":"He B, Niu L, Li S, Li H, Hou Y, Li A, et al. Sustainable inflammatory activation following spinal cord injury is driven by thrombin-mediated dynamic expression of astrocytic chemokines. Brain Behav Immun 2024, 116: 85\u2013100.","journal-title":"Brain Behav Immun"},{"key":"1519_CR175","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.pain.2007.05.023","volume":"135","author":"RX Zhang","year":"2008","unstructured":"Zhang RX, Li A, Liu B, Wang L, Ren K, Zhang H, et al. IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain 2008, 135: 232\u2013239.","journal-title":"Pain"},{"key":"1519_CR176","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.celrep.2016.11.043","volume":"17","author":"Y Nam","year":"2016","unstructured":"Nam Y, Kim JH, Kim JH, Jha MK, Jung JY, Lee MG, et al. Reversible induction of pain hypersensitivity following optogenetic stimulation of spinal astrocytes. Cell Rep 2016, 17: 3049\u20133061.","journal-title":"Cell Rep"},{"key":"1519_CR177","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.neuint.2003.06.002","volume":"45","author":"FY Tanga","year":"2004","unstructured":"Tanga FY, Raghavendra V, DeLeo JA. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int 2004, 45: 397\u2013407.","journal-title":"Neurochem Int"},{"key":"1519_CR178","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.conb.2014.07.010","volume":"29","author":"BK Lau","year":"2014","unstructured":"Lau BK, Vaughan CW. Descending modulation of pain: The GABA disinhibition hypothesis of analgesia. Curr Opin Neurobiol 2014, 29: 159\u2013164.","journal-title":"Curr Opin Neurobiol"},{"key":"1519_CR179","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.tips.2014.05.006","volume":"35","author":"RJ Vandenberg","year":"2014","unstructured":"Vandenberg RJ, Ryan RM, Carland JE, Imlach WL, Christie MJ. Glycine transport inhibitors for the treatment of pain. Trends Pharmacol Sci 2014, 35: 423\u2013430.","journal-title":"Trends Pharmacol Sci"},{"key":"1519_CR180","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s00018-005-5107-2","volume":"62","author":"HU Zeilhofer","year":"2005","unstructured":"Zeilhofer HU. The glycinergic control of spinal pain processing. Cell Mol Life Sci 2005, 62: 2027\u20132035.","journal-title":"Cell Mol Life Sci"},{"key":"1519_CR181","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1152\/physrev.00025.2021","volume":"103","author":"JC Pressey","year":"2023","unstructured":"Pressey JC, de Saint-Rome M, Raveendran VA, Woodin MA. Chloride transporters controlling neuronal excitability. Physiol Rev 2023, 103: 1095\u20131135.","journal-title":"Physiol Rev"},{"key":"1519_CR182","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1471-4159.2005.03431.x","volume":"95","author":"RD Gosselin","year":"2005","unstructured":"Gosselin RD, Varela C, Banisadr G, Mechighel P, Rostene W, Kitabgi P, et al. Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1\/CCL2 of GABA-induced currents in spinal cord neurones. J Neurochem 2005, 95: 1023\u20131034.","journal-title":"J Neurochem"},{"key":"1519_CR183","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuropharm.2013.05.045","volume":"73","author":"S Caioli","year":"2013","unstructured":"Caioli S, Pieri M, Antonini A, Guglielmotti A, Severini C, Zona C. Monocyte chemoattractant protein-1 upregulates GABA-induced current: Evidence of modified GABAA subunit composition in cortical neurons from the G93A mouse model of amyotrophic lateral sclerosis. Neuropharmacology 2013, 73: 247\u2013260.","journal-title":"Neuropharmacology"},{"key":"1519_CR184","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0963689718811060","volume":"28","author":"S Wang","year":"2019","unstructured":"Wang S. Historical review: Opiate addiction and opioid receptors. Cell Transplant 2019, 28: 233\u2013238.","journal-title":"Cell Transplant"},{"key":"1519_CR185","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/S0140-6736(19)30430-1","volume":"393","author":"LA Colvin","year":"2019","unstructured":"Colvin LA, Bull F, Hales TG. Perioperative opioid analgesia-when is enough too much? A review of opioid-induced tolerance and hyperalgesia. Lancet 2019, 393: 1558\u20131568.","journal-title":"Lancet"},{"key":"1519_CR186","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1007\/s12264-022-01009-2","volume":"39","author":"F Du","year":"2023","unstructured":"Du F, Yin G, Han L, Liu X, Dong D, Duan K, et al. Targeting peripheral \u03bc-opioid receptors or \u03bc-opioid receptor-expressing neurons does not prevent morphine-induced mechanical allodynia and anti-allodynic tolerance. Neurosci Bull 2023, 39: 1210\u20131228.","journal-title":"Neurosci Bull"},{"key":"1519_CR187","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-neuro-080317-061522","volume":"41","author":"G Corder","year":"2018","unstructured":"Corder G, Castro DC, Bruchas MR, Scherrer G. Endogenous and exogenous opioids in pain. Annu Rev Neurosci 2018, 41: 453\u2013473.","journal-title":"Annu Rev Neurosci"},{"key":"1519_CR188","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0026-895X(25)13175-1","volume":"44","author":"Y Chen","year":"1993","unstructured":"Chen Y, Mestek A, Liu J, Hurley JA, Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 1993, 44: 8\u201312.","journal-title":"Mol Pharmacol"},{"key":"1519_CR189","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1742-2094-3-32","volume":"3","author":"R Bryan Rock","year":"2006","unstructured":"Bryan Rock R, Hu S, Sheng WS, Peterson PK. Morphine stimulates CCL2 production by human neurons. J Neuroinflammation 2006, 3: 32.","journal-title":"J Neuroinflammation"},{"key":"1519_CR190","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbi.2024.12.011","volume":"124","author":"J Ju","year":"2025","unstructured":"Ju J, Ren J, Li Z, Liu J, Peng X, Zhao W, et al. Unraveling morphine tolerance: CCL2 induces spinal cord apoptosis via inhibition of Nrf2 signaling pathway and PGC-1\u03b1-mediated mitochondrial biogenesis. Brain Behav Immun 2025, 124: 347\u2013362.","journal-title":"Brain Behav Immun"},{"key":"1519_CR191","first-page":"398","volume":"12","author":"M Vincenzi","year":"2022","unstructured":"Vincenzi M, Milella MS, D\u2019Ottavio G, Caprioli D, Reverte I, Maftei D. Targeting chemokines and chemokine GPCRs to enhance strong opioid efficacy in neuropathic pain. Life (Basel) 2022, 12: 398.","journal-title":"Life (Basel)"},{"key":"1519_CR192","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1189\/jlb.0710402","volume":"89","author":"C Happel","year":"2011","unstructured":"Happel C, Kutzler M, Rogers TJ. Opioid-induced chemokine expression requires NF-\u03baB activity: The role of PKC\u03b6. J Leukoc Biol 2011, 89: 301\u2013309.","journal-title":"J Leukoc Biol"},{"key":"1519_CR193","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/MAJ.0b013e31826a82ce","volume":"344","author":"CM Zhao","year":"2012","unstructured":"Zhao CM, Guo RX, Hu F, Meng JL, Mo LQ, Chen PX, et al. Spinal MCP-1 contributes to the development of morphine antinociceptive tolerance in rats. Am J Med Sci 2012, 344: 473\u2013479.","journal-title":"Am J Med Sci"},{"key":"1519_CR194","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-021-02335-4","volume":"18","author":"M Heles","year":"2021","unstructured":"Heles M, Mrozkova P, Sulcova D, Adamek P, Spicarova D, Palecek J. Chemokine CCL2 prevents opioid-induced inhibition of nociceptive synaptic transmission in spinal cord dorsal horn. J Neuroinflammation 2021, 18: 279.","journal-title":"J Neuroinflammation"},{"key":"1519_CR195","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s11481-017-9729-6","volume":"12","author":"K Kwiatkowski","year":"2017","unstructured":"Kwiatkowski K, Piotrowska A, Rojewska E, Makuch W, Mika J. The RS504393 influences the level of nociceptive factors and enhances opioid analgesic potency in neuropathic rats. J Neuroimmune Pharmacol 2017, 12: 402\u2013419.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1519_CR196","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cyto.2019.03.007","volume":"119","author":"K Kwiatkowski","year":"2019","unstructured":"Kwiatkowski K, Popiolek-Barczyk K, Piotrowska A, Rojewska E, Ciapa\u0142a K, Makuch W, et al. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia. Cytokine 2019, 119: 202\u2013213.","journal-title":"Cytokine"},{"key":"1519_CR197","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1074\/jbc.274.10.6027","volume":"274","author":"H Ali","year":"1999","unstructured":"Ali H, Richardson RM, Haribabu B, Snyderman R. Chemoattractant receptor cross-desensitization. J Biol Chem 1999, 274: 6027\u20136030.","journal-title":"J Biol Chem"},{"key":"1519_CR198","doi-asserted-by":"publisher","first-page":"10276","DOI":"10.1073\/pnas.102327699","volume":"99","author":"I Szabo","year":"2002","unstructured":"Szabo I, Chen XH, Xin L, Adler MW, Howard OZ, Oppenheim JJ, et al. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci U S A 2002, 99: 10276\u201310281.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1519_CR199","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrn3858","volume":"16","author":"SM Parsadaniantz","year":"2015","unstructured":"Parsadaniantz SM, Rivat C, Rost\u00e8ne W, Goazigo AR. Opioid and chemokine receptor crosstalk: A promising target for pain therapy? Nat Rev Neurosci 2015, 16: 69\u201378.","journal-title":"Nat Rev Neurosci"},{"key":"1519_CR200","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1359-6101(02)00007-2","volume":"13","author":"AD Steele","year":"2002","unstructured":"Steele AD, Szabo I, Bednar F, Rogers TJ. Interactions between opioid and chemokine receptors: Heterologous desensitization. Cytokine Growth Factor Rev 2002, 13: 209\u2013222.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1519_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107846","volume":"225","author":"YQ Zhou","year":"2021","unstructured":"Zhou YQ, Mei W, Tian XB, Tian YK, Liu DQ, Ye DW. The therapeutic potential of Nrf2 inducers in chronic pain: Evidence from preclinical studies. Pharmacol Ther 2021, 225: 107846.","journal-title":"Pharmacol Ther"},{"key":"1519_CR202","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/imm.13172","volume":"159","author":"K Pawlik","year":"2020","unstructured":"Pawlik K, Piotrowska A, Kwiatkowski K, Ciapa\u0142a K, Popiolek-Barczyk K, Makuch W, et al. The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain. Immunology 2020, 159: 413\u2013428.","journal-title":"Immunology"},{"key":"1519_CR203","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuroscience.2020.06.025","volume":"441","author":"J Bogacka","year":"2020","unstructured":"Bogacka J, Ciapa\u0142a K, Pawlik K, Dobrogowski J, Przeklasa-Muszynska A, Mika J. Blockade of CCR4 diminishes hypersensitivity and enhances opioid analgesia\u2014evidence from a mouse model of diabetic neuropathy. Neuroscience 2020, 441: 77\u201392.","journal-title":"Neuroscience"},{"key":"1519_CR204","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1189\/jlb.0405222","volume":"78","author":"MW Adler","year":"2005","unstructured":"Adler MW, Rogers TJ. Are chemokines the third major system in the brain? J Leukoc Biol 2005, 78: 1204\u20131209.","journal-title":"J Leukoc Biol"},{"key":"1519_CR205","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1471-4159.2002.00809.x","volume":"81","author":"G Banisadr","year":"2002","unstructured":"Banisadr G, Qu\u00e9raud-Lesaux F, Boutterin MC, P\u00e9laprat D, Zalc B, Rost\u00e8ne W, et al. Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem 2002, 81: 257\u2013269.","journal-title":"J Neurochem"},{"key":"1519_CR206","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nrn.2016.68","volume":"17","author":"TVP Bliss","year":"2016","unstructured":"Bliss TVP, Collingridge GL, Kaang BK, Zhuo M. Synaptic plasticity in the anterior cingulate cortex in acute and chronic pain. Nat Rev Neurosci 2016, 17: 485\u2013496.","journal-title":"Nat Rev Neurosci"},{"key":"1519_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108052","volume":"170","author":"V Neugebauer","year":"2020","unstructured":"Neugebauer V, Mazzitelli M, Cragg B, Ji G, Navratilova E, Porreca F. Amygdala, neuropeptides, and chronic pain-related affective behaviors. Neuropharmacology 2020, 170: 108052.","journal-title":"Neuropharmacology"},{"key":"1519_CR208","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081744","volume":"8","author":"K Ataka","year":"2013","unstructured":"Ataka K, Asakawa A, Nagaishi K, Kaimoto K, Sawada A, Hayakawa Y, et al. Bone marrow-derived microglia infiltrate into the paraventricular nucleus of chronic psychological stress-loaded mice. PLoS One 2013, 8: e81744.","journal-title":"PLoS One"},{"key":"1519_CR209","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3389\/fnins.2014.00447","volume":"8","author":"ES Wohleb","year":"2015","unstructured":"Wohleb ES, McKim DB, Sheridan JF, Godbout JP. Monocyte trafficking to the brain with stress and inflammation: A novel axis of immune-to-brain communication that influences mood and behavior. Front Neurosci 2015, 8: 447.","journal-title":"Front Neurosci"},{"key":"1519_CR210","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/s41593-017-0034-8","volume":"21","author":"J Lisman","year":"2018","unstructured":"Lisman J, Buzs\u00e1ki G, Eichenbaum H, Nadel L, Ranganath C, David Redish A. Publisher Correction: Viewpoints: How the hippocampus contributes to memory, navigation and cognition. Nat Neurosci 2018, 21: 1018.","journal-title":"Nat Neurosci"},{"key":"1519_CR211","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neubiorev.2017.04.030","volume":"79","author":"LEB Bettio","year":"2017","unstructured":"Bettio LEB, Rajendran L, Gil-Mohapel J. The effects of aging in the hippocampus and cognitive decline. Neurosci Biobehav Rev 2017, 79: 66\u201386.","journal-title":"Neurosci Biobehav Rev"},{"key":"1519_CR212","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s11481-016-9660-2","volume":"11","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Tang H, Xiong H. Chemokine CCL2 enhances NMDA receptor-mediated excitatory postsynaptic current in rat hippocampal slices-a potential mechanism for HIV-1-associated neuropathy? J Neuroimmune Pharmacol 2016, 11: 306\u2013315.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1519_CR213","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s12264-024-01236-9","volume":"40","author":"E Ji","year":"2024","unstructured":"Ji E, Zhang Y, Li Z, Wei L, Wu Z, Li Y, et al. The chemokine CCL2 promotes excitatory synaptic transmission in hippocampal neurons via GluA1 subunit trafficking. Neurosci Bull 2024, 40: 1649\u20131666.","journal-title":"Neurosci Bull"},{"key":"1519_CR214","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12974-019-1399-2","volume":"16","author":"K Nordengen","year":"2019","unstructured":"Nordengen K, Kirsebom BE, Henjum K, Selnes P, G\u00edslad\u00f3ttir B, Wettergreen M, et al. Glial activation and inflammation along the Alzheimer\u2019s disease continuum. J Neuroinflammation 2019, 16: 46.","journal-title":"J Neuroinflammation"},{"key":"1519_CR215","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3389\/fimmu.2020.00997","volume":"11","author":"A Joly-Amado","year":"2020","unstructured":"Joly-Amado A, Hunter J, Quadri Z, Zamudio F, Rocha-Rangel PV, Chan D, et al. CCL2 overexpression in the brain promotes glial activation and accelerates tau pathology in a mouse model of tauopathy. Front Immunol 2020, 11: 997.","journal-title":"Front Immunol"},{"key":"1519_CR216","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s12272-013-0161-z","volume":"36","author":"S Bose","year":"2013","unstructured":"Bose S, Cho J. Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases. Arch Pharm Res 2013, 36: 1039\u20131050.","journal-title":"Arch Pharm Res"},{"key":"1519_CR217","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/sj.jcbfm.9600229","volume":"26","author":"OB Dimitrijevic","year":"2006","unstructured":"Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J Cereb Blood Flow Metab 2006, 26: 797\u2013810.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1519_CR218","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00018-013-1459-1","volume":"71","author":"Y Yao","year":"2014","unstructured":"Yao Y, Tsirka SE. Monocyte chemoattractant protein-1 and the blood-brain barrier. Cell Mol Life Sci 2014, 71: 683\u2013697.","journal-title":"Cell Mol Life Sci"},{"key":"1519_CR219","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12974-024-03309-y","volume":"21","author":"S Ai","year":"2024","unstructured":"Ai S, Arutyunov A, Liu J, Hill JD, Jiang X, Klein RS. CCR2 restricts IFN-\u03b3 production by hippocampal CD8 TRM cells that impair learning and memory during recovery from WNV encephalitis. J Neuroinflammation 2024, 21: 330.","journal-title":"J Neuroinflammation"},{"key":"1519_CR220","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.neuron.2019.03.003","volume":"102","author":"DC Castro","year":"2019","unstructured":"Castro DC, Bruchas MR. A motivational and neuropeptidergic hub: Anatomical and functional diversity within the nucleus accumbens shell. Neuron 2019, 102: 529\u2013552.","journal-title":"Neuron"},{"key":"1519_CR221","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4103\/1673-5374.266909","volume":"15","author":"HN Harris","year":"2020","unstructured":"Harris HN, Peng YB. Evidence and explanation for the involvement of the nucleus accumbens in pain processing. Neural Regen Res 2020, 15: 597\u2013605.","journal-title":"Neural Regen Res"},{"key":"1519_CR222","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.1523\/JNEUROSCI.0824-05.2005","volume":"25","author":"P Gubellini","year":"2005","unstructured":"Gubellini P, Ben-Ari Y, Ga\u00efarsa JL. Endogenous neurotrophins are required for the induction of GABAergic long-term potentiation in the neonatal rat hippocampus. J Neurosci 2005, 25: 5796\u20135802.","journal-title":"J Neurosci"},{"key":"1519_CR223","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/j.pain.0000000000001083","volume":"159","author":"D Liu","year":"2018","unstructured":"Liu D, Tang QQ, Yin C, Song Y, Liu Y, Yang JX, et al. Brain-derived neurotrophic factor-mediated projection-specific regulation of depressive-like and nociceptive behaviors in the mesolimbic reward circuitry. Pain 2018, 159: 175.","journal-title":"Pain"},{"key":"1519_CR224","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.neubiorev.2003.11.008","volume":"27","author":"GF Gebhart","year":"2004","unstructured":"Gebhart GF. Descending modulation of pain. Neurosci Biobehav Rev 2004, 27: 729\u2013737.","journal-title":"Neurosci Biobehav Rev"},{"key":"1519_CR225","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/SPC.0000000000000055","volume":"8","author":"MH Ossipov","year":"2014","unstructured":"Ossipov MH, Morimura K, Porreca F. Descending pain modulation and chronification of pain. Curr Opin Support Palliat Care 2014, 8: 143\u2013151.","journal-title":"Curr Opin Support Palliat Care"},{"key":"1519_CR226","first-page":"447","volume":"47","author":"CC De Preter","year":"2024","unstructured":"De Preter CC, Heinricher MM. The \u201cin\u2019s and out\u2019s\u201d of descending pain modulation from the rostral ventromedial medulla. Trends Neurosci 2024, 47: 447\u2013460.","journal-title":"Trends Neurosci"},{"key":"1519_CR227","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0166-2236(02)02157-4","volume":"25","author":"F Porreca","year":"2002","unstructured":"Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci 2002, 25: 319\u2013325.","journal-title":"Trends Neurosci"},{"key":"1519_CR228","doi-asserted-by":"publisher","first-page":"174480691983190","DOI":"10.1177\/1744806919831909","volume":"15","author":"HD Ni","year":"2019","unstructured":"Ni HD, Xu LS, Wang Y, Li H, An K, Liu M, et al. Astrocyte activation in the periaqueductal gray promotes descending facilitation to cancer-induced bone pain through the JNK MAPK signaling pathway. Mol Pain 2019, 15: 1744806919831909.","journal-title":"Mol Pain"},{"key":"1519_CR229","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbi.2014.10.016","volume":"45","author":"J Van Steenwinckel","year":"2015","unstructured":"Van Steenwinckel J, Auvynet C, Sapienza A, Reaux-Le Goazigo A, Combadi\u00e8re C, Melik Parsadaniantz S. Stromal cell-derived CCL2 drives neuropathic pain states through myeloid cell infiltration in injured nerve. Brain Behav Immun 2015, 45: 198\u2013210.","journal-title":"Brain Behav Immun"},{"key":"1519_CR230","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/fcp.12182","volume":"30","author":"M Llori\u00e1n-Salvador","year":"2016","unstructured":"Llori\u00e1n-Salvador M, Pevida M, Gonz\u00e1lez-Rodr\u00edguez S, Lastra A, Fern\u00e1ndez-Garc\u00eda MT, Hidalgo A, et al. Analgesic effects evoked by a CCR2 antagonist or an anti-CCL2 antibody in inflamed mice. Fundam Clin Pharmacol 2016, 30: 235\u2013247.","journal-title":"Fundam Clin Pharmacol"},{"key":"1519_CR231","doi-asserted-by":"publisher","first-page":"174480691878868","DOI":"10.1177\/1744806918788681","volume":"14","author":"Y Wang","year":"2018","unstructured":"Wang Y, Ni H, Li H, Deng H, Xu LS, Xu S, et al. Nuclear factor kappa B regulated monocyte chemoattractant protein-1\/chemokine CC motif receptor-2 expressing in spinal cord contributes to the maintenance of cancer-induced bone pain in rats. Mol Pain 2018, 14: 1744806918788681.","journal-title":"Mol Pain"},{"key":"1519_CR232","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neulet.2012.04.026","volume":"517","author":"JH Hu","year":"2012","unstructured":"Hu JH, Zheng XY, Yang JP, Wang LN, Ji FH. Involvement of spinal monocyte chemoattractant protein-1 (MCP-1) in cancer-induced bone pain in rats. Neurosci Lett 2012, 517: 60\u201363.","journal-title":"Neurosci Lett"},{"key":"1519_CR233","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.bbi.2020.11.015","volume":"91","author":"L Zhang","year":"2021","unstructured":"Zhang L, Xie W, Zhang J, Shanahan H, Tonello R, Lee SH, et al. Key role of CCR2-expressing macrophages in a mouse model of low back pain and radiculopathy. Brain Behav Immun 2021, 91: 556\u2013567.","journal-title":"Brain Behav Immun"},{"key":"1519_CR234","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106540","volume":"84","author":"K Kwiatkowski","year":"2020","unstructured":"Kwiatkowski K, Ciapa\u0142a K, Rojewska E, Makuch W, Mika J. Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: Behavioral and biochemical analyses. Int Immunopharmacol 2020, 84: 106540.","journal-title":"Int Immunopharmacol"},{"key":"1519_CR235","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneuroim.2016.04.017","volume":"297","author":"A Piotrowska","year":"2016","unstructured":"Piotrowska A, Kwiatkowski K, Rojewska E, Slusarczyk J, Makuch W, Basta-Kaim A, et al. Direct and indirect pharmacological modulation of CCL2\/CCR2 pathway results in attenuation of neuropathic pain\u2014in vivo and in vitro evidence. J Neuroimmunol 2016, 297: 9\u201319.","journal-title":"J Neuroimmunol"},{"key":"1519_CR236","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1744-8069-9-40","volume":"9","author":"JJ Gallagher","year":"2013","unstructured":"Gallagher JJ, Tajerian M, Guo T, Shi X, Li W, Zheng M, et al. Acute and chronic phases of complex regional pain syndrome in mice are accompanied by distinct transcriptional changes in the spinal cord. Mol Pain 2013, 9: 40.","journal-title":"Mol Pain"},{"key":"1519_CR237","doi-asserted-by":"publisher","first-page":"174480691775132","DOI":"10.1177\/1744806917751322","volume":"14","author":"A Aye-Mon","year":"2018","unstructured":"Aye-Mon A, Hori K, Kozakai Y, Nakagawa T, Hiraga S, Nakamura T, et al. CCR2 upregulation in DRG neurons plays a crucial role in gastric hyperalgesia associated with diabetic gastropathy. Mol Pain 2018, 14: 1744806917751322.","journal-title":"Mol Pain"},{"key":"1519_CR238","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/j.1532-2149.2013.00377.x","volume":"18","author":"C Dauvergne","year":"2014","unstructured":"Dauvergne C, Molet J, Reaux-Le Goazigo A, Mauborgne A, M\u00e9lik-Parsadaniantz S, Boucher Y, et al. Implication of the chemokine CCL2 in trigeminal nociception and traumatic neuropathic orofacial pain. Eur J Pain 2014, 18: 360\u2013375.","journal-title":"Eur J Pain"},{"key":"1519_CR239","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s12013-014-0510-7","volume":"72","author":"F Ren","year":"2015","unstructured":"Ren F, Jiao H, Cai H. Analgesic effect of intrathecal administration of chemokine receptor CCR2 antagonist is related to change in spinal NR2B, nNOS, and SIGIRR expression in rat with bone cancer pain. Cell Biochem Biophys 2015, 72: 611\u2013616.","journal-title":"Cell Biochem Biophys"},{"key":"1519_CR240","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnint.2018.00049","volume":"12","author":"W Guo","year":"2018","unstructured":"Guo W, Imai S, Yang JL, Zou S, Li H, Xu H, et al. NF-KappaB pathway is involved in bone marrow stromal cell-produced pain relief. Front Integr Neurosci 2018, 12: 49.","journal-title":"Front Integr Neurosci"},{"key":"1519_CR241","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1744-8069-6-90","volume":"6","author":"A Serrano","year":"2010","unstructured":"Serrano A, Par\u00e9 M, McIntosh F, Elmes SJR, Martino G, Jomphe C, et al. Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain. Mol Pain 2010, 6: 90.","journal-title":"Mol Pain"},{"key":"1519_CR242","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13075-021-02486-y","volume":"23","author":"S Ishihara","year":"2021","unstructured":"Ishihara S, Obeidat AM, Wokosin DL, Ren D, Miller RJ, Malfait AM, et al. The role of intra-articular neuronal CCR2 receptors in knee joint pain associated with experimental osteoarthritis in mice. Arthritis Res Ther 2021, 23: 103.","journal-title":"Arthritis Res Ther"},{"key":"1519_CR243","doi-asserted-by":"publisher","first-page":"174480691665396","DOI":"10.1177\/1744806916653969","volume":"12","author":"V B\u00e9gin-Lavall\u00e9e","year":"2016","unstructured":"B\u00e9gin-Lavall\u00e9e V, Midavaine \u00c9, Dansereau MA, T\u00e9treault P, Longpr\u00e9 JM, Jacobi AM, et al. Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development. Mol Pain 2016, 12: 1744806916653969.","journal-title":"Mol Pain"},{"key":"1519_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107242","volume":"205","author":"\u00c9 Midavaine","year":"2024","unstructured":"Midavaine \u00c9, Brouillette RL, Th\u00e9berge E, Mona CE, Kashem SW, C\u00f4t\u00e9 J, et al. Discovery of a CCR2-targeting pepducin therapy for chronic pain. Pharmacol Res 2024, 205: 107242.","journal-title":"Pharmacol Res"},{"key":"1519_CR245","doi-asserted-by":"publisher","first-page":"R580","DOI":"10.1152\/ajpregu.00240.2012","volume":"303","author":"ML Quick","year":"2012","unstructured":"Quick ML, Mukherjee S, Rudick CN, Done JD, Schaeffer AJ, Thumbikat P. CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis. Am J Physiol Regul Integr Comp Physiol 2012, 303: R580\u2013R589.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1519_CR246","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.615327","volume":"11","author":"K Kwiatkowski","year":"2020","unstructured":"Kwiatkowski K, Pawlik K, Ciapa\u0142a K, Piotrowska A, Makuch W, Mika J. Bidirectional action of cenicriviroc, a CCR2\/CCR5 antagonist, results in alleviation of pain-related behaviors and potentiation of opioid analgesia in rats with peripheral neuropathy. Front Immunol 2020, 11: 615327.","journal-title":"Front Immunol"},{"key":"1519_CR247","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pain.2011.09.022","volume":"153","author":"SSV Padi","year":"2012","unstructured":"Padi SSV, Shi XQ, Zhao YQ, Ruff MR, Baichoo N, Pert CB, et al. Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation. Pain 2012, 153: 95\u2013106.","journal-title":"Pain"},{"key":"1519_CR248","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120788","volume":"306","author":"MR Ruff","year":"2022","unstructured":"Ruff MR, Inan S, Shi XQ, Meissler JJ, Adler MW, Eisenstein TK, et al. Potentiation of morphine antinociception and inhibition of diabetic neuropathic pain by the multi-chemokine receptor antagonist peptide RAP-103. Life Sci 2022, 306: 120788.","journal-title":"Life Sci"},{"key":"1519_CR249","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s12264-023-01126-6","volume":"40","author":"Y Yang","year":"2024","unstructured":"Yang Y, Yang W, Zhang R, Wang Y. Peripheral mechanism of cancer-induced bone pain. Neurosci Bull 2024, 40: 815\u2013830.","journal-title":"Neurosci Bull"},{"key":"1519_CR250","doi-asserted-by":"publisher","first-page":"174480692311693","DOI":"10.1177\/17448069231169373","volume":"19","author":"LP Zhu","year":"2023","unstructured":"Zhu LP, Xu ML, Yuan BT, Ma LJ, Gao YJ. Chemokine CCL7 mediates trigeminal neuropathic pain via CCR2\/CCR3-ERK pathway in the trigeminal ganglion of mice. Mol Pain 2023, 19: 17448069231169372.","journal-title":"Mol Pain"},{"key":"1519_CR251","doi-asserted-by":"publisher","first-page":"8893","DOI":"10.1523\/JNEUROSCI.2209-07.2007","volume":"27","author":"P Zhao","year":"2007","unstructured":"Zhao P, Waxman SG, Hains BC. Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21. J Neurosci 2007, 27: 8893\u20138902.","journal-title":"J Neurosci"},{"key":"1519_CR252","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.pain.2013.07.002","volume":"154","author":"ZJ Zhang","year":"2013","unstructured":"Zhang ZJ, Cao DL, Zhang X, Ji RR, Gao YJ. Chemokine contribution to neuropathic pain: Respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons. Pain 2013, 154: 2185\u20132197.","journal-title":"Pain"},{"key":"1519_CR253","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.expneurol.2014.05.014","volume":"261","author":"DL Cao","year":"2014","unstructured":"Cao DL, Zhang ZJ, Xie RG, Jiang BC, Ji RR, Gao YJ. Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2. Exp Neurol 2014, 261: 328\u2013336.","journal-title":"Exp Neurol"},{"key":"1519_CR254","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1742-2094-11-38","volume":"11","author":"J Xu","year":"2014","unstructured":"Xu J, Zhu MD, Zhang X, Tian H, Zhang JH, Wu XB, et al. NF\u03baB-mediated CXCL1 production in spinal cord astrocytes contributes to the maintenance of bone cancer pain in mice. J Neuroinflammation 2014, 11: 38.","journal-title":"J Neuroinflammation"},{"key":"1519_CR255","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12264-020-00608-1","volume":"37","author":"YF Kong","year":"2021","unstructured":"Kong YF, Sha WL, Wu XB, Zhao LX, Ma LJ, Gao YJ. CXCL10\/CXCR3 signaling in the DRG exacerbates neuropathic pain in mice. Neurosci Bull 2021, 37: 339\u2013352.","journal-title":"Neurosci Bull"},{"key":"1519_CR256","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1172\/JCI81950","volume":"126","author":"BC Jiang","year":"2016","unstructured":"Jiang BC, Cao DL, Zhang X, Zhang ZJ, He LN, Li CH, et al. CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5. J Clin Invest 2016, 126: 745\u2013761.","journal-title":"J Clin Invest"},{"key":"1519_CR257","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12974-016-0652-1","volume":"13","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Cao DL, Zhang ZJ, Jiang BC, Gao YJ. Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5\/ERK pathway in the trigeminal ganglion of mice. J Neuroinflammation 2016, 13: 183.","journal-title":"J Neuroinflammation"},{"key":"1519_CR258","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/j.1460-9568.2004.03593.x","volume":"20","author":"GM Verge","year":"2004","unstructured":"Verge GM, Milligan ED, Maier SF, Watkins LR, Naeve GS, Foster AC. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root Ganglia under basal and neuropathic pain conditions. Eur J Neurosci 2004, 20: 1150\u20131160.","journal-title":"Eur J Neurosci"},{"key":"1519_CR259","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.bbi.2006.11.003","volume":"21","author":"ZY Zhuang","year":"2007","unstructured":"Zhuang ZY, Kawasaki Y, Tan PH, Wen YR, Huang J, Ji RR. Role of the CX3CR1\/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 2007, 21: 642\u2013651.","journal-title":"Brain Behav Immun"},{"key":"1519_CR260","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s12264-023-01075-0","volume":"39","author":"H Xian","year":"2023","unstructured":"Xian H, Guo H, Liu YY, Zhang JL, Hu WC, Yu MJ, et al. Peripheral BDNF regulates somatosensory-sympathetic coupling in brachial plexus avulsion-induced neuropathic pain. Neurosci Bull 2023, 39: 1789\u20131806.","journal-title":"Neurosci Bull"},{"key":"1519_CR261","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s12264-023-01152-4","volume":"40","author":"S Zhang","year":"2024","unstructured":"Zhang S, Chen Y, Wang Y, Wang H, Yao D, Chen G. Tau accumulation in the spinal cord contributes to chronic inflammatory pain by upregulation of IL-1\u03b2 and BDNF. Neurosci Bull 2024, 40: 466\u2013482.","journal-title":"Neurosci Bull"},{"key":"1519_CR262","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.sjpain.2012.10.003","volume":"4","author":"J Kalliom\u00e4ki","year":"2013","unstructured":"Kalliom\u00e4ki J, Jonzon B, Huizar K, O\u2019Malley M, Andersson A, Simpson DM. Evaluation of a novel chemokine receptor 2 (CCR2)-antagonist in painful diabetic polyneuropathy. Scand J Pain 2013, 4: 77\u201383.","journal-title":"Scand J Pain"},{"key":"1519_CR263","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.pain.2013.02.003","volume":"154","author":"J Kalliom\u00e4ki","year":"2013","unstructured":"Kalliom\u00e4ki J, Attal N, Jonzon B, Bach FW, Huizar K, Ratcliffe S, et al. A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia. Pain 2013, 154: 761\u2013767.","journal-title":"Pain"},{"key":"1519_CR264","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399409000921","volume":"11","author":"R Horuk","year":"2009","unstructured":"Horuk R. Promiscuous drugs as therapeutics for chemokine receptors. Expert Rev Mol Med 2009, 11: e1.","journal-title":"Expert Rev Mol Med"},{"key":"1519_CR265","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.3390\/ijms25073788","volume":"25","author":"A Ciechanowska","year":"2024","unstructured":"Ciechanowska A, Mika J. CC chemokine family members\u2019 modulation as a novel approach for treating central nervous system and peripheral nervous system injury-a review of clinical and experimental findings. Int J Mol Sci 2024, 25: 3788.","journal-title":"Int J Mol Sci"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01519-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-025-01519-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01519-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:02:23Z","timestamp":1765454543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-025-01519-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":265,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1519"],"URL":"https:\/\/doi.org\/10.1007\/s12264-025-01519-9","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors confirm that all necessary permissions have been obtained, including the BioRender Academic Publication License for scientific illustration use.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}